Partner Content Partner Content Registration is closing soon for SMi’s 22nd Annual Pain Ther... Registrations Closing Soon
Partner Content Partner Content Top-Level industry professionals to speak at Pain Therapeuti... 2 weeks Pain Therapeutics Conference - expert speakers
Partner Content Partner Content Due to COVID-19, Pain Therapeutics Conference, May 2020 will... COVID-19 means Pain Therapeutics Conference is Remote
Partner Content Partner Content Chair invite Kerrie Brady & Michael Scherz released ahead of... Invite from Chairs Pain Therapeutics
Partner Content Partner Content Exclusive Speaker Interview with Stephen Hunt, Professor, UC... Exclusive Speaker Interview with Stephen Hunt
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
